Perfil
Sri Mudumba is currently the Chief Preclinical Research Officer at PYC Therapeutics Ltd.
Previously, Dr. Mudumba worked as the Director-Product Development at MacuSight, Inc.
Cargos activos de Sri Mudumba
| Empresas | Cargo | Inicio |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Sri Mudumba.
| Empresas | Cargo | Fin |
|---|---|---|
MacuSight, Inc.
 MacuSight, Inc. Pharmaceuticals: MajorHealth Technology MacuSight, Inc. develops and manufactures pharmaceuticals products. The firm engages in developing therapeutics for the treatment of severe ocular diseases and conditions. It offers sirolimus, a therapeutic for the treatment and prevention of wet age-related macular degeneration, as well as for the treatment of diabetic macular edema; and related compounds and other select therapeutics in the eye, as well as minimally-invasive ocular formulations. The company was founded in 2003 and is headquartered in Union City, CA. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PYC THERAPEUTICS LIMITED | Health Technology |
| Empresas privadas | 1 |
|---|---|
MacuSight, Inc.
MacuSight, Inc. Pharmaceuticals: MajorHealth Technology MacuSight, Inc. develops and manufactures pharmaceuticals products. The firm engages in developing therapeutics for the treatment of severe ocular diseases and conditions. It offers sirolimus, a therapeutic for the treatment and prevention of wet age-related macular degeneration, as well as for the treatment of diabetic macular edema; and related compounds and other select therapeutics in the eye, as well as minimally-invasive ocular formulations. The company was founded in 2003 and is headquartered in Union City, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Sri Mudumba
